These alterations are already found in early precursor lesions such as PanIN, following inactivation of tumor suppressor genes such as CDKN2A, TP53m or SMAD4, which in turn contribute to an enhancement of the tumor stroma. The gene discussed is CDKN2A; the disease is neoplasm.